Inventaire - dine venner og fællesskaber er dit bedste bibliotek

Osteoprotegerin is an independent predictor of vascular events in Finnish adults with type 1 diabetes

forfatter

Allan Flyvbjerg

Daniel Gordin

Merlin Thomas

Per-Henrik Groop

FinnDiane Study Group

Carol Forsblom

1964 - 2022

Valma Harjutsalo

Markku Saraheimo

Aino Soro-Paavonen

Mette Bjerre

udgivet i: Diabetes Care

dato for udgivelse: 2013-07-01

sprog: engelsk

main subject: type 1-diabetes, Finland

Cites articles 30

Date

Titel

Forfattere

2012-08-16

Quality of the Finnish Hospital Discharge Register: a systematic review

Reijo Sund
2012-05-27

Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease

Evangelos Oikonomou, Gerasimos Siasos, Christodoulos I. Stefanadis, Dimitris Tousoulis
2010-10-07

Osteoprotegerin and mortality in type 2 diabetic patients

Peter Rossing, Lars M Rasmussen, Lise Tarnow, Hans-Henrik Parving, Maria Lajer, Mari-Anne Gall
2010-02-01

Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily

Allan Flyvbjerg
2010-08-01

Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial

Aldo P. Maggioni, Valentina Milani, Allan Flyvbjerg, Luigi Tavazzi, Torbjørn Omland
2010-01-30

Serum osteoprotegerin, sRANKL and carotid plaque formation and growth in a general population--the Tromsø study

Inger Njølstad, Ellisiv Mathiesen, Stein Harald Johnsen
2009-05-05

A new equation to estimate glomerular filtration rate

Josef Coresh, John W Kusek, Harold I Feldman
2009-04-28

The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes

Per-Henrik Groop, FinnDiane Study Group, Milla Rosengård-Bärlund, Ville-Petteri Mäkinen, Lena M Thorn, Merlin Thomas, Carol Forsblom, Outi Saarenpää-Heikkilä, Kustaa Hietala, Markku Saraheimo
2009-11-11

Human full-length osteoprotegerin induces the proliferation of rodent vascular smooth muscle cells both in vitro and in vivo

Stella Bernardi, Bruno Fabris, Barbara Toffoli, Riccardo Candido, Federica Corallini
2008-08-22

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy

Anders Jorsal, Lise Tarnow, Peter Rossing, Lars M Rasmussen
2007-07-01

Increased OPG expression and impaired OPG/TRAIL ratio in the aorta of diabetic rats

Mauro Vaccarezza
2006-01-01

Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients.

Lars M Rasmussen, Lise Tarnow, Allan Flyvbjerg
2006-04-19

The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects
2006-09-25

Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice

Paola Secchiero, Serena Zacchigna, Bruno Fabris, Mauro Giacca, Giorgio Zauli, Erika Rimondi, Federica Corallini, Barbara Toffoli, Riccardo Candido
2005-02-08

Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha

Lars M Rasmussen
2005-12

Osteoprotegerin serum levels in children with type 1 diabetes: a potential modulating role in bone status

Stefano Stagi, Gabriele Simonini
2004-08-01

Vascular calcification in patients with end-stage renal disease
2003-05-15

Osteoclast differentiation and activation
2003-07-01

Increased plasma concentrations of osteoprotegerin in type 2 diabetic patients with microvascular complications
2003-03-01

Increased osteoprotegerin serum levels in men with coronary artery disease

Lorenz C Hofbauer
2003-01-30

Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification

Qiuping Zhang, Catherine Shanahan
2002-04-01

RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function

Klaus. T. Preissner, Lorenz C Hofbauer
2002-02

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification
2001-01-01

Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells

Colin Dunstan, B. Lawrence Riggs
2001-02-01

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women
2001-07-01

Osteoprotegerin: a link between osteoporosis and arterial calcification?

Lorenz C Hofbauer
2000-08-01

Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis

Colin Dunstan
1998-05-01

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Colin Dunstan
1997-04-01

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Colin Dunstan, Margaret L. DeRose
1996-02-28

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

Artikel - wd:Q36942172

Welcome to Inventaire

dit venne- og fællesskabs bibliotek

vil du vide mere